$450.00+1.42%Close 13 Nov 2026 · Market value $55.10B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Humana is valued at $55.10B on its latest close. Its price is 44.2 times its earnings.
| Market value | $55.10B |
|---|
| Enterprise value | $41.50B |
|---|
| Price / earnings | 44.22 |
|---|
| Price / sales | 0.36 |
|---|
| Price / book | 2.93 |
|---|
| EV / EBITDA | 13.72 |
|---|
| EV / sales | 0.27 |
|---|
| Price / free cash flow | 17.55 |
|---|
| Price / free cash flow, own 5-year average | 20.84 |
|---|
| EV / EBIT | 17.85 |
|---|
| EV / free cash flow | 13.54 |
|---|
| Free cash flow yield | 5.7% |
|---|
| Dividend yield | 0.8% |
|---|
Share price
| Latest close | $450.00 |
|---|
| Day's change | +1.4% |
|---|
| 52-week high | $456.50 |
|---|
| 52-week low | $163.11 |
|---|
| From 52-week high | −1.4% |
|---|
| Return · 1 month | +8.9% |
|---|
| Return · 3 months | +18.2% |
|---|
| Return · year to date | +75.7% |
|---|
| Return · 1 year | +87.1% |
|---|
| Beta · 1 year against the S&P 500 | 0.55 |
|---|
| 50-day average | $408.68 |
|---|
| 200-day average | $317.35 |
|---|
| RSI 14 | 64.5 |
|---|
| Average volume · 20 sessions | 1.6M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Operating margin | 2.1% |
|---|
| Net margin | 0.9% |
|---|
| Free cash flow margin | 0.3% |
|---|
| Return on equity | 7.0% |
|---|
| Return on assets | 4.7% |
|---|
| Return on invested capital | 13.3% |
|---|
| Return on invested capital, 5-year average | 14.1% |
|---|
| Return on capital employed | 8.7% |
|---|
| Stock-based compensation / revenue | 0.2% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $4.20B |
|---|
| Total debt | $12.91B |
|---|
| Net debt | −$6.99B |
|---|
| Current ratio | 2.00 |
|---|
| Quick ratio | 1.04 |
|---|
| Debt / equity | 0.73 |
|---|
| Net debt / EBITDA | −2.05 |
|---|
| Interest coverage | 4.29 |
|---|
Growth
| Revenue, latest quarter on a year | +26.1% |
|---|
| Revenue, twelve months on a year | +22.0% |
|---|
| EPS, latest quarter on a year | −17.9% |
|---|
| EPS, twelve months on a year | −3.8% |
|---|
| Revenue, 5-year compound | +10.9% |
|---|
| Revenue, 10-year compound | +9.1% |
|---|
| Net income, 5-year compound | −18.8% |
|---|
| Free cash flow, 5-year compound | −39.6% |
|---|
| EPS, 5-year compound | −17.2% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 121M |
|---|
| Shares outstanding, 5-year compound | −1.9% |
|---|
| Net share repurchases | $151.0M |
|---|
| Dividends per share | $3.54 |
|---|
| Dividend payout | 36.2% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $250.0M |
|---|
| Effective tax rate | 17.4% |
|---|
HUM in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.